clinical trial · NCT00394160
Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)
Organon and Co·phase2·completed·n = 12
BronchiolitisMK0476, Montelukast Sodium /Duration of Treatment : 14 Days
brief summary
The purpose of this study is to look at the preliminary safety profile of an investigational drug in children 1 to \< 3 months of age with bronchiolitis.
started
Dec 1, 2004
primary completion
Oct 1, 2005
completion
Oct 1, 2005
last updated
Aug 15, 2024
official title
A Randomized, 3-Period, Multiple-Dose, Multicenter Study to Evaluate the Safety, Tolerability, and Plasma Concentration Profile of Montelukast Administered Once Daily as Oral Granules in Children Aged 1 to 3 Months
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol